Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit.
Journal
The American journal on addictions
ISSN: 1521-0391
Titre abrégé: Am J Addict
Pays: England
ID NLM: 9208821
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
revised:
08
03
2021
received:
27
11
2020
accepted:
02
05
2021
pubmed:
3
6
2021
medline:
26
11
2021
entrez:
2
6
2021
Statut:
ppublish
Résumé
The prevalence of substance use disorders (SUD), particularly involving opiates and benzodiazepines, has increased to the detriment of public health and the economy. Here, we evaluate relapse factors among the high-risk demographic of patients with SUD and comorbid affective disorders. A retrospective chart review of 76 patients discharged after detoxification and simultaneous psychiatric care for concomitant affective disorders and SUDs. Relapse was assessed by two independent evaluators via postdischarge chart review, which included state-wide healthcare utilization, by patient, through healthcare information exchange systems. A Cox Hazards analysis was performed to characterize relapse risk factors. Benzodiazepine use, admission through the emergency department (ED) rather than direct admission, frequent ED use in the preceding year, and history of prior attendance at multiple detoxification programs were risk factors for shortened time-to-relapse. Polysubstance use and intravenous drug use prolonged time to relapse. Notable findings include the significant relapse risk associated with benzodiazepine abuse and frequent prior ED utilization. These risk factors could reflect a number of underlying mediators for relapse, including anxiety, disease burden, and malingering. Additionally, this study recapitulates the observation in other patient populations that the majority of health resource utilization is attributed to a small population of patients. This study is the first to identify relapse predictors among dual-diagnosis affective disorder and SUD patients in survival analysis, and replicates the alarming and largely unknown effect that benzodiazepines have on increasing relapse risk.
Sections du résumé
BACKGROUND AND OBJECTIVES
The prevalence of substance use disorders (SUD), particularly involving opiates and benzodiazepines, has increased to the detriment of public health and the economy. Here, we evaluate relapse factors among the high-risk demographic of patients with SUD and comorbid affective disorders.
METHODS
A retrospective chart review of 76 patients discharged after detoxification and simultaneous psychiatric care for concomitant affective disorders and SUDs. Relapse was assessed by two independent evaluators via postdischarge chart review, which included state-wide healthcare utilization, by patient, through healthcare information exchange systems. A Cox Hazards analysis was performed to characterize relapse risk factors.
RESULTS
Benzodiazepine use, admission through the emergency department (ED) rather than direct admission, frequent ED use in the preceding year, and history of prior attendance at multiple detoxification programs were risk factors for shortened time-to-relapse. Polysubstance use and intravenous drug use prolonged time to relapse.
DISCUSSION AND CONCLUSIONS
Notable findings include the significant relapse risk associated with benzodiazepine abuse and frequent prior ED utilization. These risk factors could reflect a number of underlying mediators for relapse, including anxiety, disease burden, and malingering. Additionally, this study recapitulates the observation in other patient populations that the majority of health resource utilization is attributed to a small population of patients.
SCIENTIFIC SIGNIFICANCE
This study is the first to identify relapse predictors among dual-diagnosis affective disorder and SUD patients in survival analysis, and replicates the alarming and largely unknown effect that benzodiazepines have on increasing relapse risk.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
461-467Informations de copyright
© 2021 The Authors. The American Journal on Addictions published by Wiley Periodicals LLC on behalf of The American Academy of Addiction Psychiatry (AAAP).
Références
Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull. 1998;24(4):589-608. https://doi.org/10.1093/oxfordjournals.schbul.a033351
Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511-2518.
Pavarin RM, Fioritti A, Fontana F, Marani S, Paparelli A, Boncompagni G. Emergency department admission and mortality rate for suicidal behavior. Crisis. 2014;35(6):406-414. https://doi.org/10.1027/0227-5910/a000282
Kleespies PM, ed. Behavioral Emergencies: An Evidence-Based Resource for Evaluating and Managing Risk of Suicide, Violence, and Victimization. Washington, DC: American Psychological Association; 2009. https://doi.org/10.1037/11865-000
Xie H, McHugo GJ, Fox MB, Drake RE. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatr Serv. 2005;56(10):1282-1287. https://doi.org/10.1176/appi.ps.56.10.1282
Durazzo TC, Meyerhoff DJ. Psychiatric, demographic, and brain morphological predictors of relapse after treatment for an alcohol use disorder. Alcohol Clin Exp Res. 2017;41(1):107-116. https://doi.org/10.1111/acer.13267
Harvey R, Jason LA, Ferrari JR. Substance abuse relapse in Oxford House recovery homes: a survival analysis evaluation. Subst Abus. 2016;37(2):281-285. https://doi.org/10.1080/08897077.2015.1080786
Wahler EA, Otis MD. Social stress, economic hardship, and psychological distress as predictors of sustained abstinence from substance use after treatment. Subst Use Misuse. 2014;49(13):1820-1832. https://doi.org/10.3109/10826084.2014.935789
Kline-Simon AH, Chi FW, Mertens JR, Weisner C. Trajectories of remission and mortality over 13 years after intake to substance use treatment. Am J Drug Alcohol Abuse. 2017;43(5):583-590. https://doi.org/10.1080/00952990.2016.1271883
Ferri M, Finlayson AJR, Wang L, Martin PR. Predictive factors for relapse in patients on buprenorphine maintenance. Am J Addict. 2014;23(1):62-67. https://doi.org/10.1111/j.1521-0391.2013.12074.x
National Drug Intelligence Center. National Drug Threat Assessment; 2011. www.justice.gov/ndicADNET; https://www.adnet.smil.mil/web/ndic/index.htmLEO; https://www.leo.gov/; http://leowcs.leopriv.gov/lesig/ndic/index.htmJWICS; http://www.intelink.ic.gov/sites/. Accessed June 18, 2019.
Hawk K, D'Onofrio G. Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract. 2018;13(1):18. https://doi.org/10.1186/s13722-018-0117-1
Ondler C, Hegde GG, Carlson JN. Resource utilization and health care charges associated with the most frequent ED users. Am J Emerg Med. 2014;32(10):1215-1219. https://doi.org/10.1016/J.AJEM.2014.07.013
Bieler G, Paroz S, Faouzi M, et al. Social and medical vulnerability factors of emergency department frequent users in a universal health insurance system. Acad Emerg Med. 2012;19(1):63-68. https://doi.org/10.1111/j.1553-2712.2011.01246.x
Sun BC, Burstin HR, Brennan TA. Predictors and outcomes of frequent emergency department users. Acad Emerg Med. 2003;10(4):320-328.
Martens MS, Zurhold H, Rosenkranz M, et al. Using life course charts to assess and compare trajectories of amphetamine type stimulant consumption in different user groups: a cross-sectional study. Harm Reduct J. 2020;17(1):8. https://doi.org/10.1186/s12954-019-0339-x
Rosenkranz M, O'donnell A, Verthein U, et al. Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol. BMJ Open. 2019;9(8):e029476. https://doi.org/10.1136/bmjopen-2019-029476
Benningfield MM, Dietrich MS, Jones HE, et al. Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addiction. 2012;107(1):74-82. https://doi.org/10.1111/J.1360-0443.2012.04041.X
Fox JK, Halpern LF, Ryan JL, Lowe KA. Stressful life events and the tripartite model: Relations to anxiety and depression in adolescent females. J Adolesc. 2010;33(1):43-54. https://doi.org/10.1016/j.adolescence.2009.05.009
Alverson H, Alverson M, Drake RE. An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness. Community Ment Health J. 2000;36(6):557-569.
Grover CA, Close RJ. Frequent users of the emergency department: risky business. West J Emerg Med. 2009;10(3):193-194.
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46. https://doi.org/10.1097/00001648-199001000-00010
Bender R, Lange S. Adjusting for multiple testing-when and how? J Clin Epidemiol. 2001;54(4):343-349. https://doi.org/10.1016/S0895-4356(00)00314-0